Global Gene Editing Market Overview:
Global Gene Editing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Gene Editing Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Gene Editing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Gene Editing Market:
The Gene Editing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Gene Editing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Gene Editing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Gene Editing market has been segmented into:
CRISPR
TALEN
ZFN
Antisense
and others
By Application, Gene Editing market has been segmented into:
Genetic Engineering
Gene Therapy
Cell Line Engineering
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Gene Editing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Gene Editing market.
Top Key Players Covered in Gene Editing market are:
GE Healthcare(US)
Thermo Fisher Scientific Inc (US)
Bio-Rad Laboratories
Inc (US)
Lonza (Switzerland)
GenScript (US)
Horizon Discovery Ltd (UK)
OriGene Technologies
Inc (US)
Integrated DNA Technologies
Inc (US)
New England Biolabs
Inc (US)
Sangamo Therapeutics(US)
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Gene Editing Market Type
4.1 Gene Editing Market Snapshot and Growth Engine
4.2 Gene Editing Market Overview
4.3 CRISPR
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 CRISPR: Geographic Segmentation Analysis
4.4 TALEN
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 TALEN: Geographic Segmentation Analysis
4.5 ZFN
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 ZFN: Geographic Segmentation Analysis
4.6 Antisense
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Antisense: Geographic Segmentation Analysis
4.7 and others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 and others: Geographic Segmentation Analysis
Chapter 5: Gene Editing Market Application
5.1 Gene Editing Market Snapshot and Growth Engine
5.2 Gene Editing Market Overview
5.3 Genetic Engineering
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Genetic Engineering: Geographic Segmentation Analysis
5.4 Gene Therapy
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Gene Therapy: Geographic Segmentation Analysis
5.5 Cell Line Engineering
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Cell Line Engineering: Geographic Segmentation Analysis
5.6 and Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Gene Editing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 GE HEALTHCARE(US)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 THERMO FISHER SCIENTIFIC INC (US)
6.4 BIO-RAD LABORATORIES
6.5 INC (US)
6.6 LONZA (SWITZERLAND)
6.7 GENSCRIPT (US)
6.8 HORIZON DISCOVERY LTD (UK)
6.9 ORIGENE TECHNOLOGIES
6.10 INC (US)
6.11 INTEGRATED DNA TECHNOLOGIES
6.12 INC (US)
6.13 NEW ENGLAND BIOLABS
6.14 INC (US)
6.15 SANGAMO THERAPEUTICS(US)
Chapter 7: Global Gene Editing Market By Region
7.1 Overview
7.2. North America Gene Editing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 CRISPR
7.2.2.2 TALEN
7.2.2.3 ZFN
7.2.2.4 Antisense
7.2.2.5 and others
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Genetic Engineering
7.2.3.2 Gene Therapy
7.2.3.3 Cell Line Engineering
7.2.3.4 and Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Gene Editing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 CRISPR
7.3.2.2 TALEN
7.3.2.3 ZFN
7.3.2.4 Antisense
7.3.2.5 and others
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Genetic Engineering
7.3.3.2 Gene Therapy
7.3.3.3 Cell Line Engineering
7.3.3.4 and Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Gene Editing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 CRISPR
7.4.2.2 TALEN
7.4.2.3 ZFN
7.4.2.4 Antisense
7.4.2.5 and others
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Genetic Engineering
7.4.3.2 Gene Therapy
7.4.3.3 Cell Line Engineering
7.4.3.4 and Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Gene Editing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 CRISPR
7.5.2.2 TALEN
7.5.2.3 ZFN
7.5.2.4 Antisense
7.5.2.5 and others
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Genetic Engineering
7.5.3.2 Gene Therapy
7.5.3.3 Cell Line Engineering
7.5.3.4 and Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Gene Editing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 CRISPR
7.6.2.2 TALEN
7.6.2.3 ZFN
7.6.2.4 Antisense
7.6.2.5 and others
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Genetic Engineering
7.6.3.2 Gene Therapy
7.6.3.3 Cell Line Engineering
7.6.3.4 and Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Gene Editing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 CRISPR
7.7.2.2 TALEN
7.7.2.3 ZFN
7.7.2.4 Antisense
7.7.2.5 and others
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Genetic Engineering
7.7.3.2 Gene Therapy
7.7.3.3 Cell Line Engineering
7.7.3.4 and Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Gene Editing Scope:
|
Report Data
|
Gene Editing Market
|
|
Gene Editing Market Size in 2025
|
USD XX million
|
|
Gene Editing CAGR 2025 - 2032
|
XX%
|
|
Gene Editing Base Year
|
2024
|
|
Gene Editing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GE Healthcare(US), Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories, Inc (US), Lonza (Switzerland), GenScript (US), Horizon Discovery Ltd (UK), OriGene Technologies, Inc (US), Integrated DNA Technologies, Inc (US), New England Biolabs, Inc (US), Sangamo Therapeutics(US).
|
|
Key Segments
|
By Type
CRISPR
TALEN
ZFN
Antisense
and others
By Applications
Genetic Engineering
Gene Therapy
Cell Line Engineering
and Others
|
